Skip to the page

Data / Form D filings / OrthoBio Therapeutics, Inc.

OrthoBio Therapeutics, Inc.: Form D filing

OrthoBio Therapeutics, Inc., a biotechnology company in Vail, CO, filed a Form D with the SEC in 2025. The latest, on July 2, 2025, reports $31.4 million sold of a $31.4 million offering to 45 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1300 N. Frontage Road, #5937, Vail, CO, 81657
Phone
(970) 376-8517
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1904099

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 2, 2025New notice$31,449,768$31,449,76845Jun 23, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Jessica T. HopfieldDirector
Stanley T. ShumanDirector
Marc J. PrisantExecutive Officer
Peter J. MillettExecutive Officer, Director
Lodewijk J. de VinkDirector
William T. EsreyDirector
Robert T. HuginDirector

Other biotechnology companies in Colorado that filed recently

Every Form D from the week of Jun 30, 2025 · All recent filings in Colorado · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what OrthoBio Therapeutics, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.